University of Bonn, Department of Nuclear Medicine, Bonn, Germany.
Anticancer Res. 2010 May;30(5):1741-5.
The synergy between in vitro and in vivo imaging was investigated in this study.
Comparison of fluorodeoxyglucose positron-emission tomography (FDG-PET) and computerised tomography (CT) included 62 patients (group 1), while that for comparison of FDG-PET and serum tumour markers included 26 patients (group 2).
In group 1, FDG-PET had positive and negative predictive values of 81% and 80% respectively, compared to 73.7% and 71.4% for CT, respectively. Combined imaging showed 100% sensitivity and 100% specificity. In group 2, FDG-PET and CEA were both positive in 42.9%, and only CEA was falsely negative in all other cases. FDG-PET and TPA were both positive in 47.6%, and in 52.4% only FDG-PET was positive. NSE and SCC had 100% specificity; their sensitivity was 38% and 25%, respectively.
FDG-PET diagnosis was improved by CT. Because the serum tumour markers were falsely negative in more than 50% and there were no falsely negative results for FDG-PET, combined imaging may allow reduction of cut-off values for conventional serum tumour markers.
本研究旨在探讨体外与体内成像的协同作用。
62 例患者(第 1 组)进行了氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)与计算机断层扫描(CT)的比较,26 例患者(第 2 组)进行了 FDG-PET 与血清肿瘤标志物的比较。
第 1 组中,FDG-PET 的阳性预测值和阴性预测值分别为 81%和 80%,而 CT 分别为 73.7%和 71.4%。联合成像显示出 100%的灵敏度和 100%的特异性。第 2 组中,CEA 和 FDG-PET 均为阳性的占 42.9%,而其他所有病例 CEA 均为假阴性。TPA 和 FDG-PET 均为阳性的占 47.6%,而 52.4%仅 FDG-PET 为阳性。NSE 和 SCC 的特异性均为 100%;其灵敏度分别为 38%和 25%。
CT 提高了 FDG-PET 的诊断准确性。由于血清肿瘤标志物的假阴性率超过 50%,而 FDG-PET 无假阴性结果,因此联合成像可能会降低传统血清肿瘤标志物的截断值。